Ciforadenant is a pharmaceutical raw material that functions as a potent, selective, oral A2A receptor antagonist. It is under investigation in clinical trials for attention deficit/hyperactivity disorder (ADHD).
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Ciforadenant?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(+/-)-(cis)-dorzolamide hydrochloride
pharmaceutical raw material
Dorzolamide
pharmaceutical raw material
Cetrorelix
pharmaceutical raw material
Biapenem
pharmaceutical raw material
The international HS code for Ciforadenant (CAS 1202402-40-1) is 2934.99.
2934.99
2934 99 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
7-(5-methylfuran-2-yl)-3-[[6-[[(3S)-oxolan-3-yl]oxymethyl]-2-pyridinyl]methyl]triazolo[4,5-d]pyrimidin-5-amine
KURQKNMKCGYWRJ-HNNXBMFYSA-N
CC1=CC=C(O1)C2=C3C(=NC(=N2)N)N(N=N3)CC4=NC(=CC=C4)CO[C@H]5CCOC5
Sourcing Ciforadenant?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.